US Stock MarketDetailed Quotes
ABVC ABVC BioPharma
- 0.5480
- +0.0013+0.24%
Close Oct 18 16:00 ET
- 0.5285
- -0.0195-3.56%
Post 19:56 ET
6.81MMarket Cap-330P/E (TTM)
0.5521High0.5280Low62.25KVolume0.5521Open0.5467Pre Close33.16KTurnover0.65%Turnover RatioLossP/E (Static)12.42MShares3.350052wk High0.82P/B5.25MFloat Cap0.405352wk Low--Dividend TTM9.57MShs Float116.9000Historical High--Div YieldTTM4.41%Amplitude0.4053Historical Low0.5320Avg Price1Lot Size
ABVC BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,817.53%117.14K | -99.06%1.21K | -84.28%152.43K | -99.63%2.17K | -62.42%15.88K | -98.05%6.11K | 399.89%128.27K | 172.57%969.78K | 1,658.47%588.99K | -57.30%42.27K |
| Operating revenue | 1,817.53%117.14K | -99.06%1.21K | -84.28%152.43K | -99.63%2.17K | -62.42%15.88K | -98.05%6.11K | 399.89%128.27K | 172.57%969.78K | 1,658.47%588.99K | -57.30%42.27K |
| Cost of revenue | -99.74%190 | -99.54%277 | 5.45%302.04K | -47.55%139.21K | 175.71%29.61K | 772.25%72.98K | 3,077.00%60.24K | 5,531.44%286.42K | 9,372.20%265.41K | 2,633.08%10.74K |
| Gross profit | 274.89%116.95K | -98.64%928 | -121.89%-149.61K | -142.35%-137.04K | -143.55%-13.73K | -121.96%-66.87K | 186.30%68.04K | 94.85%683.37K | 897.10%323.58K | -68.03%31.53K |
| Operating expense | -48.58%1.09M | 74.52%3.45M | -48.94%8.07M | -47.21%1.82M | -42.86%2.14M | -9.54%2.13M | -68.37%1.97M | 35.07%15.8M | -45.15%3.46M | 93.48%3.75M |
| Selling and administrative expenses | -34.69%1.05M | 105.96%3.38M | -46.55%7M | -10.63%1.75M | -41.90%2M | -11.33%1.61M | -72.14%1.64M | 18.56%13.1M | -68.10%1.96M | 90.61%3.44M |
| -General and administrative expense | -34.69%1.05M | 105.96%3.38M | -46.55%7M | -10.63%1.75M | -41.90%2M | -11.33%1.61M | -72.14%1.64M | 18.56%13.1M | -68.10%1.96M | 90.61%3.44M |
| Research and development costs | -92.15%40.4K | -79.38%69.07K | -60.54%1.06M | -95.17%72.19K | -53.74%141.31K | -3.44%514.44K | -6.80%334.98K | 168.32%2.69M | 474.89%1.5M | 15.97%305.48K |
| Operating profit | 55.48%-976.64K | -80.70%-3.44M | 45.64%-8.22M | 37.39%-1.96M | 42.01%-2.15M | -7.18%-2.19M | 69.35%-1.91M | -33.22%-15.11M | 50.61%-3.13M | -102.14%-3.72M |
| Net non-operating interest income expense | -290.03%-232.89K | -17,122.52%-680.63K | -2,074.13%-2.31M | -1,340.33%-1.07M | -1,403.57%-1.18M | -346.16%-59.71K | -117.99%-3.95K | 42.31%-106.15K | -1,373.77%-74K | -167.08%-78.37K |
| Non-operating interest income | -50.69%27.14K | -92.32%4.05K | -1.24%185.48K | -38.01%37.48K | -16.44%40.25K | 41.08%55.04K | 31.20%52.71K | 334.80%187.82K | 305.74%60.46K | 416.06%48.16K |
| Non-operating interest expense | 126.60%260.03K | 1,108.34%684.68K | 748.17%2.49M | 720.54%1.1M | 863.07%1.22M | 677.56%114.75K | 211.11%56.66K | 29.38%293.97K | 651.82%134.46K | 227.16%126.54K |
| Other net income (expense) | -969.26%-174.05K | 1,015.80%144.01K | 55.82%-129.91K | 61.63%-127.02K | -263.52%-35.83K | 378.83%20.02K | -42.07%12.91K | -192.39%-294.03K | -172.29%-331.04K | 123.22%21.91K |
| Gain on sale of security | -542.80%-117.67K | 1,025.86%113.52K | 25.37%-199.2K | 49.58%-143.57K | -14,057.63%-25.06K | -274.68%-18.31K | -262.12%-12.26K | -270.58%-266.91K | -179.01%-284.77K | 99.82%-177 |
| Earnings from equity interest | ---79.06K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Special income (charges) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---110.13K | ---- | ---- |
| -Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --110.13K | ---- | ---- |
| Other non- operating income (expenses) | -40.85%22.67K | 21.13%30.49K | -16.53%69.28K | -74.07%16.56K | -148.75%-10.77K | 317.03%38.33K | 71.04%25.17K | -48.70%83K | -34.53%63.86K | 545.85%22.09K |
| Income before tax | 38.05%-1.38M | -109.83%-3.98M | 31.33%-10.65M | 10.84%-3.15M | 10.69%-3.37M | -10.04%-2.23M | 69.27%-1.9M | -38.39%-15.51M | 39.93%-3.54M | -92.28%-3.77M |
| Income tax | -235.74%-110.89K | 0 | -67.91%256.01K | -81.79%175.31K | -123.66%-999 | 199.08%81.7K | 0 | -3.30%797.78K | -4.79%962.87K | 105.58%4.22K |
| Net income | 45.03%-1.27M | -109.83%-3.98M | 33.12%-10.91M | 26.02%-3.33M | 10.82%-3.37M | -18.89%-2.32M | 68.83%-1.9M | -35.53%-16.31M | 34.78%-4.5M | -100.21%-3.78M |
| Net income continuous Operations | 45.03%-1.27M | -109.83%-3.98M | 33.12%-10.91M | 26.02%-3.33M | 10.82%-3.37M | -18.89%-2.32M | 68.83%-1.9M | -35.53%-16.31M | 34.78%-4.5M | -100.21%-3.78M |
| Minority interest income | -402.85%-260.04K | 34.67%-48.04K | -455.96%-394.63K | -160.27%-218.82K | 29.44%-50.56K | 41.46%-51.71K | 20.22%-73.54K | -86.19%110.87K | -64.79%363.04K | 10.15%-71.66K |
| Net income attributable to the parent company | 55.26%-1.01M | -115.66%-3.93M | 35.97%-10.52M | 36.04%-3.11M | 10.46%-3.32M | -21.76%-2.26M | 69.58%-1.82M | -27.92%-16.42M | 38.68%-4.86M | -105.09%-3.7M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 55.26%-1.01M | -115.66%-3.93M | 35.97%-10.52M | 36.04%-3.11M | 10.46%-3.32M | -21.76%-2.26M | 69.58%-1.82M | -27.92%-16.42M | 38.68%-4.86M | -105.09%-3.7M |
| Basic earnings per share | 86.76%-0.09 | 27.27%-0.4 | 53.18%-2.43 | 73.44%-0.3931 | 28.07%-0.82 | -15.25%-0.68 | 72.50%-0.55 | -1.76%-5.19 | 52.26%-1.48 | -62.86%-1.14 |
| Diluted earnings per share | 86.76%-0.09 | 27.27%-0.4 | 53.18%-2.43 | 73.44%-0.3931 | 28.07%-0.82 | -15.25%-0.68 | 72.50%-0.55 | -1.76%-5.19 | 52.26%-1.48 | -62.86%-1.14 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data